📰 Nasdaq Aplt News
Nasdaq Aplt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Aplt. Real-time updates on events, politics, business and more.
April 9, 2024
Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) were down 3.7% during mid-day trading on Tuesday . The stock traded as low as $5.45 and last traded at $5.45. Approximately 133,499 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 2,099,365 shares. The stock had previously […]
April 2, 2024
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 3,790,000 shares, a decline of 12.5% from the February 29th total of 4,330,000 shares. Based on an average daily volume of 2,120,000 shares, the short-interest ratio […]
December 13, 2023
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 3,400,000 shares, an increase of 71.7% from the November 15th total of 1,980,000 shares. Based on an average daily volume of 1,070,000 shares, the short-interest ratio is currently 3.2 […]
November 5, 2023
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) major shareholder Real Estate Equitie Alexandria sold 155,000 shares of Applied Therapeutics stock in a transaction dated Tuesday, October 31st. The shares were sold at an average price of $2.41, for a total value of $373,550.00. Following the transaction, the insider now owns 6,000,077 shares of the […]
October 10, 2023
Applied Therapeutics Inc (NASDAQ: APLT)’s stock price has soared by 10.11 in relation to previous closing price of 2.22. Nevertheless, the company has seen a loss of -2.78% in its stock price over the last five trading days. GlobeNewsWire reported 2023-09-28 that The ongoing ARISE-HF Phase 3 g
October 5, 2023
Applied Therapeutics Inc (NASDAQ: APLT)’s stock price has decreased by -8.44 compared to its previous closing price of 2.43. However, the company has seen a -15.72% decrease in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-09-28 that The ongoing ARISE-HF Phase 3
September 30, 2023
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) insider Riccardo Perfetti sold 10,932 shares of Applied Therapeutics stock in a transaction on Wednesday, September 27th. The stock was sold at an average price of $2.70, for a total transaction of $29,516.40. Following the transaction, the insider now directly owns 693,924 shares in the company, valued […]
September 30, 2023
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) CEO Shoshana Shendelman sold 115,632 shares of the firm’s stock in a transaction that occurred on Wednesday, September 27th. The stock was sold at an average price of $2.70, for a total value of $312,206.40. Following the completion of the sale, the chief executive officer now directly […]
August 9, 2023
Applied Therapeutics (NASDAQ:APLT – Get Free Report) is scheduled to be releasing its earnings data on Thursday, August 10th. Applied Therapeutics (NASDAQ:APLT – Get Free Report) last announced its earnings results on Thursday, May 11th. The company reported ($0.18) EPS for the quarter. The business had revenue of $10.66 million during the quarter. Applied Therapeutics […]
July 12, 2023
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report)’s stock price shot up 1.4% during trading on Tuesday . The stock traded as high as $1.44 and last traded at $1.41. 59,648 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 343,076 shares. The stock had previously closed at […]